Court appoints BDO to administer claims from investors
SRO failed to prove certain allegations, investor harm
Regulatory action deals with subset of $1.8 million misappropriation
Triple the proceeds of misconduct deemed more adequate deterrent
U.S. authorities allege biostatistician traded on cancer drug data
Concerns about company were raised by short sellers in 2022
Former rep traded investors' discount brokerage accounts for them
Regulator calls for greater clarity from industry on ESG strategies
Regulators sign MoU targeting operational resilience, incident recovery
Regs seek efficiency, innovation to facilitate single EU financial market